Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota

被引:0
|
作者
Hanyan Luo
Hongwei Wu
Lixia Wang
Shuiming Xiao
Yaqi Lu
Cong Liu
Xiankuo Yu
Xiao Zhang
Zhuju Wang
Liying Tang
机构
[1] Institute of Chinese Materia Medica,
[2] China Academy of Chinese Medical Science,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cassiae Semen (CS), the seeds of Cassia obtusifolia L. and C. tora L, have a long medicinal history in China, with suggestions for it to relieve constipation and exert hepatoprotective effects. However, the underlying mechanisms are still unclear. In this study, mice with high-fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) were used to study the hepatoprotective effects of CS. The relationship between gut microbiota and hepatoprotective effect mechanisms mediated by CS extracts, the total aglycone extracts of CS, rubrofusarin-6-β-gentiobioside, and aurantio-obtusin were examined. Our data indicate that CS extracts and components confer a protective effect by ameliorating lipid accumulation, intestinal barrier damage, liver damage, and inflammation on HFD-induced liver injury. Meanwhile, fecal microbe transplantation exerted the pharmacological effect of CS on HFD-fed mice; however, the efficacy of CS was inhibited or eliminated by antibiotic-induced dysbiosis. In conclusion, the therapeutic effects of CS on NAFLD were closely related to the gut microbiota, suggesting a role for TCM in treating disease.
引用
收藏
相关论文
共 50 条
  • [31] Gut Dysfunction and Non-alcoholic Fatty Liver Disease
    Grabherr, Felix
    Grander, Christoph
    Effenberger, Maria
    Adolph, Timon Erik
    Tilg, Herbert
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [32] Role of Nutrition, Gene Polymorphism, and Gut Microbiota in Non-alcoholic Fatty Liver Disease
    Kong, Lingbo
    Lu, Yu
    Zhang, Siyu
    Nan, Yuemin
    Qiao, Liang
    DISCOVERY MEDICINE, 2017, 24 (131) : 95 - 106
  • [33] Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota
    Han, Ruiting
    Ma, Junli
    Li, Houkai
    FRONTIERS OF MEDICINE, 2018, 12 (06) : 645 - 657
  • [34] Modulation of the gut microbiota represents a new management for non-alcoholic fatty liver disease
    Bakhshimoghaddam, Farnush
    Alizadeh, Mohammad
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (02) : 223 - 226
  • [35] Gut microbiota induced epigenetic modifications in the non-alcoholic fatty liver disease pathogenesis
    Tang, Ruiqi
    Liu, Rongrong
    Zha, Hua
    Cheng, Yiwen
    Ling, Zongxin
    Li, Lanjuan
    ENGINEERING IN LIFE SCIENCES, 2024, 24 (05):
  • [36] Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?
    Demir, Muenevver
    Lang, Sonja
    Martin, Anna
    Farowski, Fedja
    Wisplinghoff, Hilmar
    Vehreschild, Maria J. G. T.
    Krawczyk, Marcin
    Nowag, Angela
    Scholz, Claus Jurgen
    Kretzschmar, Anne
    Roderburg, Christoph
    Lammert, Frank
    Goeser, Tobias
    Kasper, Philipp
    Steffen, Hans-Michael
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (11) : 1969 - 1977
  • [37] Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents
    Tokuhara, Daisuke
    FRONTIERS IN NUTRITION, 2021, 8
  • [38] Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
    Xie, Chencheng
    Halegoua-DeMarzio, Dina
    NUTRIENTS, 2019, 11 (11)
  • [39] Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota
    Ruiting Han
    Junli Ma
    Houkai Li
    Frontiers of Medicine, 2018, 12 : 645 - 657
  • [40] Gut Microbiota as an Emerging Therapeutic Avenue for the Treatment of Non-alcoholic Fatty Liver Disease
    Ralli, Tanya
    Neupane, Yub Raj
    Saifi, Zoya
    Kohli, Kanchan
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (46) : 4677 - 4685